Virtual, via Zoom - register to receive the link via email
Access to investigational drugs has been a controversial topic during the COVID19 pandemic: what is the level of evidence required? How do we evaluate individual access requests, particularly from public figures such as outgoing Presidents? How...
Virtual, via Zoom - register to receive the link via email
Discussants: Insoo Hyun, PhD | DIrector of Research Ethics, Center for Bioethics, Harvard Medical School | Professor of Bioethics, Case Western Reserve University School of Medicine Madeline Lancaster, PhD | Group Leader, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
The human brain is greatly enlarged and elaborate compared with that of other mammals. While this complexity enables...
Harvard University, Radcliffe Institute for Advanced Study, Knafel Centre, 10 Garden Street, Cambridge, MA
From Botox to bionic limbs, the human body is more upgradable than ever. But how much can we alter and still be human? What do we gain or lose in the process?
The award-winning documentary Fixed: The Science/Fiction of Human Enhancement explores the social impact of human biotechnologies. Haunting and humorous, poignant and political, Fixed rethinks “disability” and “normalcy” by exploring technologies that promise to change our bodies and minds forever.
Harvard Medical School D-Amphitheater Armenise Building | 210 Longwood Avenue, Boston, MA 02115
The amazing "plasticity" of human cells opens up exciting new possibilities for patient diagnosis and treatment, anti-aging research, organ generation, and more. These possibilities inspire hope for new cures in the future, but many may wonder whether there ought to be ethical limits to how we harness...
University of Basel, Faculty of Law, Peter Merian-Weg 8,Pro lure Auditorium, CH-4002, Basel, Switzerland
Participation is free of charge.
Promising advances in stem cell research have been accompanied by the lack of clear regulatory frameworks leading to the situation then most of it is still in petri dishes or in early phase clinical trials. The difficult and fragmented laws on stem cell research and application give no clear guidelines for scientific activities in this field. This conference will bring together legal practitioners and academics with natural science scientists and medical doctors to discuss the stem cell research regulation in the EU and Switzerland,...
Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product. This panel of experts will discuss the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal...